Literature DB >> 26254956

Heroin abuse exaggerates age-related deposition of hyperphosphorylated tau and p62-positive inclusions.

Gabor G Kovacs1, Monika Cs Horvath2, Katalin Majtenyi3, Mirjam I Lutz4, Yasmin L Hurd5, Eva Keller6.   

Abstract

The observation of increased hyperphosphorylated tau levels correlating with microglial activation in opiate abusers has been interpreted as predisposition to accelerated Alzheimer disease-related changes. The present study focused on evaluating additional neurodegeneration-related proteins, including α-synuclein and TDP-43, and p62-positive deposits. We performed a systematic mapping of protein deposits in the brains of 27 individuals with documented heroin addiction (age: 19-40 years) and compared with 11 controls (age: 15-40 years). We confirm previous findings that heroin addiction associates with tau hyperphosphorylation in predilection brain areas for aging and Alzheimer disease. Furthermore, we show that this occurs also in areas implicated in the molecular disturbances and in vivo neuronal networks related to heroin abuse. There was, however, no presence of amyloid-beta deposits. We extend previous findings by showing the lack of TDP-43 or α-synuclein pathology and emphasize the independent effect of the duration of drug use on the appearance of age-related p62-positive neuritic profiles. These observations provide unique insights about neuropathological alterations in the brains of young heroin addicts and have implications about brain aging and the influences of environmental and toxic factors.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; Heroin; Neuropathology; Opiate; TDP-43; Tau; p62; α-Synuclein

Mesh:

Substances:

Year:  2015        PMID: 26254956      PMCID: PMC4609594          DOI: 10.1016/j.neurobiolaging.2015.07.018

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  31 in total

1.  Hyperphosphorylated tau and amyloid precursor protein deposition is increased in the brains of young drug abusers.

Authors:  S N Ramage; I C Anthony; F W Carnie; A Busuttil; R Robertson; J E Bell
Journal:  Neuropathol Appl Neurobiol       Date:  2005-08       Impact factor: 8.090

Review 2.  The neuropathology of heroin abuse.

Authors:  A Büttner; G Mall; R Penning; S Weis
Journal:  Forensic Sci Int       Date:  2000-09-11       Impact factor: 2.395

3.  Ubiquitin immunoreactive structures in normal human brains. Distribution and developmental aspects.

Authors:  D W Dickson; A Wertkin; Y Kress; H Ksiezak-Reding; S H Yen
Journal:  Lab Invest       Date:  1990-07       Impact factor: 5.662

4.  Distinctive profiles of gene expression in the human nucleus accumbens associated with cocaine and heroin abuse.

Authors:  Dawn N Albertson; Carl J Schmidt; Gregory Kapatos; Michael J Bannon
Journal:  Neuropsychopharmacology       Date:  2006-05-03       Impact factor: 7.853

Review 5.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

6.  Phases of A beta-deposition in the human brain and its relevance for the development of AD.

Authors:  Dietmar R Thal; Udo Rüb; Mario Orantes; Heiko Braak
Journal:  Neurology       Date:  2002-06-25       Impact factor: 9.910

7.  Identification of normal and pathological aging in prospectively studied nondemented elderly humans.

Authors:  D W Dickson; H A Crystal; L A Mattiace; D M Masur; A D Blau; P Davies; S H Yen; M K Aronson
Journal:  Neurobiol Aging       Date:  1992 Jan-Feb       Impact factor: 4.673

8.  Morphogenesis of Lewy bodies: dissimilar incorporation of alpha-synuclein, ubiquitin, and p62.

Authors:  Erkki Kuusisto; Laura Parkkinen; Irina Alafuzoff
Journal:  J Neuropathol Exp Neurol       Date:  2003-12       Impact factor: 3.685

9.  Profile of executive and memory function associated with amphetamine and opiate dependence.

Authors:  Karen D Ersche; Luke Clark; Mervyn London; Trevor W Robbins; Barbara J Sahakian
Journal:  Neuropsychopharmacology       Date:  2006-05       Impact factor: 7.853

10.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.

Authors:  Heiko Braak; Irina Alafuzoff; Thomas Arzberger; Hans Kretzschmar; Kelly Del Tredici
Journal:  Acta Neuropathol       Date:  2006-08-12       Impact factor: 17.088

View more
  23 in total

Review 1.  Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Authors:  Marc J Kaufman; Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Neurosci Biobehav Rev       Date:  2019-02-25       Impact factor: 8.989

2.  Total hypothalamic volume is reduced in postmortem brains of male heroin addicts.

Authors:  Ulf J Müller; Kolja Schiltz; Christian Mawrin; Henrik Dobrowolny; Thomas Frodl; Hans-Gert Bernstein; Bernhard Bogerts; Kurt Truebner; Johann Steiner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-05-22       Impact factor: 5.270

3.  Is biological aging accelerated in drug addiction?

Authors:  Keren Bachi; Salvador Sierra; Nora D Volkow; Rita Z Goldstein; Nelly Alia-Klein
Journal:  Curr Opin Behav Sci       Date:  2017-02

Review 4.  Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy.

Authors:  Gabor G Kovacs; Isidro Ferrer; Lea T Grinberg; Irina Alafuzoff; Johannes Attems; Herbert Budka; Nigel J Cairns; John F Crary; Charles Duyckaerts; Bernardino Ghetti; Glenda M Halliday; James W Ironside; Seth Love; Ian R Mackenzie; David G Munoz; Melissa E Murray; Peter T Nelson; Hitoshi Takahashi; John Q Trojanowski; Olaf Ansorge; Thomas Arzberger; Atik Baborie; Thomas G Beach; Kevin F Bieniek; Eileen H Bigio; Istvan Bodi; Brittany N Dugger; Mel Feany; Ellen Gelpi; Stephen M Gentleman; Giorgio Giaccone; Kimmo J Hatanpaa; Richard Heale; Patrick R Hof; Monika Hofer; Tibor Hortobágyi; Kurt Jellinger; Gregory A Jicha; Paul Ince; Julia Kofler; Enikö Kövari; Jillian J Kril; David M Mann; Radoslav Matej; Ann C McKee; Catriona McLean; Ivan Milenkovic; Thomas J Montine; Shigeo Murayama; Edward B Lee; Jasmin Rahimi; Roberta D Rodriguez; Annemieke Rozemüller; Julie A Schneider; Christian Schultz; William Seeley; Danielle Seilhean; Colin Smith; Fabrizio Tagliavini; Masaki Takao; Dietmar Rudolf Thal; Jon B Toledo; Markus Tolnay; Juan C Troncoso; Harry V Vinters; Serge Weis; Stephen B Wharton; Charles L White; Thomas Wisniewski; John M Woulfe; Masahito Yamada; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2015-12-10       Impact factor: 17.088

5.  HIV-1 Tat and Morphine Differentially Disrupt Pyramidal Cell Structure and Function and Spatial Learning in Hippocampal Area CA1: Continuous versus Interrupted Morphine Exposure.

Authors:  William D Marks; Jason J Paris; Aaron J Barbour; Jean Moon; Valerie J Carpenter; Virginia D McLane; Arianna R S Lark; Sara R Nass; Jingli Zhang; Viktor Yarotskyy; A Rory McQuiston; Pamela E Knapp; Kurt F Hauser
Journal:  eNeuro       Date:  2021-05-24

Review 6.  Does Traumatic Brain Injury Cause Risky Substance Use or Substance Use Disorder?

Authors:  Christopher M Olsen; John D Corrigan
Journal:  Biol Psychiatry       Date:  2021-07-21       Impact factor: 13.382

7.  Classification of diseases with accumulation of Tau protein.

Authors:  Gabor G Kovacs; Bernardino Ghetti; Michel Goedert
Journal:  Neuropathol Appl Neurobiol       Date:  2022-02-09       Impact factor: 6.250

8.  Morphine and HIV-1 Tat interact to cause region-specific hyperphosphorylation of tau in transgenic mice.

Authors:  Michael Ohene-Nyako; Sara R Nass; Yun K Hahn; Pamela E Knapp; Kurt F Hauser
Journal:  Neurosci Lett       Date:  2020-11-14       Impact factor: 3.046

Review 9.  Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine.

Authors:  Gabor G Kovacs
Journal:  Int J Mol Sci       Date:  2016-02-02       Impact factor: 5.923

10.  Humoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin Users.

Authors:  Michael S Piepenbrink; Memorie Samuel; Bo Zheng; Brittany Carter; Christopher Fucile; Catherine Bunce; Michelle Kiebala; Atif A Khan; Juilee Thakar; Sanjay B Maggirwar; Diane Morse; Alexander F Rosenberg; Norman J Haughey; William Valenti; Michael C Keefer; James J Kobie
Journal:  PLoS One       Date:  2016-07-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.